Morgan Stanley Eton Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 586,046 shares of ETON stock, worth $9.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

586,046

Previous 509,568 15.01%

Holding current value

$9.9 Million

Previous $7.26 Million 76.19%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$13.89 - $22.48 $1.06 Million - $1.72 Million	76,478 Added 15.01%	586,046 $12.8 Million
Q2 2025 Aug 15, 2025	BUY	$11.47 - $20.24 $4.15 Million - $7.33 Million	362,236 Added 245.86%	509,568 $7.26 Million
Q1 2025 May 15, 2025	BUY	$11.75 - $18.25 $1.58 Million - $2.45 Million	134,139 Added 1016.74%	147,332 $1.91 Million
Q4 2024 Feb 14, 2025	BUY	$5.9 - $13.15 $75,053 - $167,281	12,721 Added 2695.13%	13,193 $173,000
Q3 2024 May 14, 2025	BUY	$3.28 - $6.0 $918 - $1,680	280 Added 145.83%	472 $2,000
Q3 2024 Nov 14, 2024	BUY	$3.28 - $6.0 $918 - $1,680	280 Added 145.83%	472 $2,000
Q2 2024 May 14, 2025	SELL	$3.06 - $3.75 $39,783 - $48,753	-13,001 Reduced 98.54%	192 $0
Q2 2024 Oct 17, 2024	BUY	$3.06 - $3.75 $471 - $577	154 Added 405.26%	192 $0
Q2 2024 Aug 14, 2024	BUY	$3.06 - $3.75 $471 - $577	154 Added 405.26%	192 $0
Q1 2024 Oct 17, 2024	SELL	$3.48 - $5.03 $535 - $774	-154 Reduced 80.21%	38 $0
Q4 2023 Aug 16, 2024	SELL	$3.45 - $4.66 $531 - $717	-154 Reduced 80.21%	38 $0
Q4 2023 Feb 13, 2024	SELL	$3.45 - $4.66 $200 - $270	-58 Reduced 60.42%	38 $0
Q3 2023 Nov 15, 2023	SELL	$2.55 - $5.63 $1,907 - $4,211	-748 Reduced 88.63%	96 $0
Q2 2023 Aug 14, 2023	SELL	$3.32 - $4.04 $6,175 - $7,514	-1,860 Reduced 68.79%	844 $2,000
Q1 2023 May 15, 2023	SELL	$2.89 - $4.1 $15,712 - $22,291	-5,437 Reduced 66.79%	2,704 $10,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $2,809 - $4,520	1,391 Added 20.61%	8,141 $22,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.03 $3,437 - $5,105	-1,685 Reduced 19.98%	6,750 $14,000
Q2 2022 Oct 27, 2022	SELL	$2.55 - $4.38 $50,071 - $86,005	-19,636 Reduced 69.95%	8,435 $23,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.38 $50,071 - $86,005	-19,636 Reduced 69.95%	8,435 $23,000
Q1 2022 Oct 27, 2022	BUY	$3.43 - $4.69 $67,351 - $92,092	19,636 Added 232.79%	28,071 $122,000
Q1 2022 May 13, 2022	SELL	$3.43 - $4.69 $6,863 - $9,384	-2,001 Reduced 6.65%	28,071 $122,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $17,117 - $30,821	-4,677 Reduced 13.46%	30,072 $129,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $6.26 $145,945 - $217,528	34,749 New	34,749 $175,000

Others Institutions Holding ETON

# of Institutions

102

Shares Held

15.9M

Call Options Held

103K

Put Options Held

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $428M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account